|
시장보고서
상품코드
2039044
골종양 절제술 기기 시장 : 기술별, 적응증별, 최종사용자별, 지역별Bone Tumor Ablation Devices Market, By Technology, By Indication, By End User, By Geography |
||||||
골종양 절제술 기기 시장은 2026년에 1억 1,100만 달러로 추정되며, 2033년까지 2억 1,930만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR은 10.2%를 보일 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 1억 1,100만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 10.20% | 예측 금액(2033년) | 2억 1,930만 달러 |
종양절제술은 체내의 종양 세포나 조직을 제거하기 위한 최소침습적 시술입니다. 종양 절제 장치는 영상 유도 하에 종양 내에 삽입되는 카테터로 구성되어 있습니다. 마이크로파 절제술용 자기 영상 유도 시스템의 도입은 복강경 절제술에서 효과적인 보조 수단이 되어 외과 의사에 대한 지원을 강화하고 환자의 치료 결과를 향상시켰습니다. 주요 기업들도 절제 장치 출시에 주력하고 있으며, 이는 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2016년 1월, 메드트로닉은 미국에서 'OsteoCool' 고주파 절제 시스템을 출시했습니다. "OsteoCool 고주파 절제 시스템은 냉각 기능을 갖춘 고주파(RF) 절제 기술입니다. 이 시스템은 고통스러운 뼈 종양의 치료에 두 개의 프로브를 동시에 사용할 수 있는 기능을 갖추고 있습니다.
시장 역학
골다공증은 골절의 흔한 원인이며, 그 유병률은 나이가 들어감에 따라 점차 증가합니다. 예를 들어, 미국 국립생물공학정보센터(NCBI)에 따르면 60세 이상 남성의 10%, 여성의 13%가 골다공증을 앓고 있다고 합니다. 미국 골다공증 재단(National Osteoporosis Foundation)의 2014년 자료에 따르면, 2013년 50세 이상 미국 성인 중 총 5,400만 명이 골다공증 및 골감소증에 영향을 받았다고 합니다. 또한 재단은 2020년까지 골절 건수가 2배에서 4배까지 증가하여 4,100만 명의 여성이 골다공증이나 골관절염을 앓게 될 것이라고 예측했습니다. 이는 주로 고령 인구의 현저한 증가에 기인합니다.
또한, 시장의 주요 기업들은 암 발병률이 높은 암 환자 치료를 위해 기술적으로 진보된 골종양 절제술 장비 개발에 주력하고 있으며, 이를 시장에 출시하기 위해 노력하고 있습니다. 예를 들어, 2018년 메릴랜드 주 볼티모어 존스홉킨스 메디컬 센터의 의사들은 전이성 골암의 척추 종양 치료에 AveCure 마이크로웨이브 절제 시스템을 성공적으로 사용했다고 보고한 바 있습니다. 또한, 2018년에는 멕시코 과달라하라의 주요 병원 의사들이 뇌종양 치료에 AveCure 마이크로웨이브 절제 시스템을 성공적으로 사용했다고 보고한 바 있습니다.
본 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 이 보고서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 골종양 절제 장치 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 골종양 절제 장치 시장' 보고서는 투자자, 유통업체, 골종양 절제 장치 공급업체, 연구 및 컨설팅 회사, 신규 참가자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 골종양 절제술 기기 시장 : 기술별(2021년-2033년)
제5장 세계의 골종양 절제술 기기 시장 : 적응증별(2021년-2033년)
제6장 세계의 골종양 절제술 기기 시장 : 최종사용자별(2021년-2033년)
제7장 세계의 골종양 절제술 기기 시장 : 지역별(2021년-2033년)
제8장 경쟁 구도
제9장 섹션
LSH 26.06.04Bone Tumor Ablation Devices Market is estimated to be valued at USD 111.0 Mn in 2026 and is expected to reach USD 219.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 10.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 111.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.20% | 2033 Value Projection: | USD 219.3 Mn |
Tumor ablation is a minimally invasive procedure to remove the tumor cells or tissue from the body. Tumor ablation devices consist of a catheter, which is introduced into the tumor under imaging guidance. The use of microwave ablation magnetic image-guiding systems has provided an effective adjunct in laparoscopic ablation, provided better support to surgeons, and increased patient outcomes. Key players are also focused on launching of ablation devices, which is expected to drive the market growth over the forecast period. For instance, in January 2016, Medtronic Plc. launched the OsteoCool radiofrequency ablation system in the U.S. OsteoCool RF Ablation system is a cooled radiofrequency (RF) ablation technology. It offers simultaneous, dual-probe capabilities for treating painful bone tumors.
Market Dynamics
Osteoporosis is a common cause for bone fractures and its prevalence gradually increases with age. For instance, according to the National Center for Biotechnology Information, osteoporosis occurs in 10% men and 13% in women, who are aged 60 years or above. According to the National Osteoporosis Foundation data of 2014, a total of 54 million U.S. adults aged 50 and older were affected by osteoporosis and low bone mass in 2013. It further states that the number of bone fractures will increase by 2 to 4 times by 2020 and 41 million women will suffer from osteoporosis or osteoarthritis. This is mainly attributed to significant rise in geriatric population.
Furthermore, key players in the market are focusing on development of technologically advanced bone tumor ablation devices for treatment of highly prevalent cancer cases and launch them in the market. For instance, in 2018, doctors at Johns Hopkins Medical Center, Baltimore, Maryland reported successful use of AveCure microwave ablation system for the treatment of Metastatic Bone Cancer spinal tumors. Moreover, in 2018, doctors at a major hospital in Guadalajara, Mexico reported successful use of AveCure microwave ablation system for the treatment of brain tumors.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global bone tumor ablation devices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global bone tumor ablation devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for bone tumor ablation devices market, research and consulting firms, new entrants, and financial analysts.
Market Segmentation
- By Technology (Revenue, USD Mn, 2021-2033)
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Others
- By Indication (Revenue, USD Mn, 2021-2033)
- Osteosarcoma
- Chondrosarcoma
- Ewing's Sarcoma
- Metastatic Bone Cancer
- Others
- By End User (Revenue, USD Mn, 2021-2033)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Medtronic Plc
- Merit Medical Systems Inc
- MedWaves Inc
- AngioDynamics Inc
- Olympus Corporation
- Varian Medical Systems Inc
- Mermaid Medical A/S
- RF Medical Co., Ltd
- Misomix Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Epidemiology
- Regulatory Scenario
- Reimbursement Scenario
- Key Developments
- PEST Analysis
4. Global Bone Tumor Ablation Devices Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Radiofrequency Ablation
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Microwave Ablation
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cryoablation
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
5. Global Bone Tumor Ablation Devices Market, By Indication, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Osteosarcoma
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Chondrosarcoma
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Ewing's Sarcoma
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Metastatic Bone Cancer
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Others
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
6. Global Bone Tumor Ablation Devices Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Ambulatory Surgical Centers
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Specialty Clinics
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
7. Global Bone Tumor Ablation Devices Market, By Region, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 - 2033
- North America
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2021-2033, (USD Mn)
- Market Size and Forecast, By Indication, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- U.S.
- Canada
- Europe
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2021-2033, (USD Mn)
- Market Size and Forecast, By Indication, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2021-2033, (USD Mn)
- Market Size and Forecast, By Indication, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2021-2033, (USD Mn)
- Market Size and Forecast, By Indication, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2021-2033, (USD Mn)
- Market Size and Forecast, By Indication, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Technology, 2021-2033, (USD Mn)
- Market Size and Forecast, By Indication, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Medtronic Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merit Medical Systems Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- MedWaves Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- AngioDynamics Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Olympus Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Varian Medical Systems, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Mermaid Medical A/S
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- RF Medical Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Misomix Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Medtronic Plc.
9. Section
- References
- Research Methodology
- About us and Sales Contact
